This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Apoptosis is a fundamental process in metazoan development. It is a central component of countless events during animal development that serve to sculpt and shape structures, eliminate obsolete tissues, and closely control cell number. Apoptosis also plays a critical role throughout the life of an organism for the maintenance of tissue architecture and homeostasis. Defects in apoptosis are associated with a several debilitating conditions including cancer, autoimmune disorders, and neurodegenerative diseases. An in-depth understanding of the mechanisms and regulation of apoptosis is central to the development of new, more effective therapies for these conditions. We propose to advance understanding of apoptotic mechanisms through study of the recently identified Drosophila morgue gene. morgue encodes an F-box protein that suppresses levels of Drosophila IAP-1 (DIAP1) to promote apoptosis in developing tissues. Our preliminary findings have shown Morgue to be a key regulator of mitochondrial membrane depolarization during apoptosis, and to be required for organelle breakdown and cell surface phosphatidylserine display. Loss of Morgue results in failure to commit to apoptosis and prolonged survival of corpse-like cells in vivo. Thus, proper regulation of Morgue activity is central to the progression of apoptosis in Drosophila.
The specific aims of this project are to a) characterize the influence of sumoylation and phosphorylation on Morgue activity, and b) characterize additional genes required for PS display and organelle breakdown. We will use a multidisciplinary approach to these experiments that will include classical genetic studies, as well as molecular and biochemical approaches.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015563-08
Application #
7609722
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2007-05-01
Project End
2008-02-29
Budget Start
2007-05-01
Budget End
2008-02-29
Support Year
8
Fiscal Year
2007
Total Cost
$20,936
Indirect Cost
Name
University of Kansas Lawrence
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
076248616
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Subramanian, Chitra; Grogan, Patrick T; Opipari, Valerie P et al. (2018) Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-?B activation. Oncotarget 9:14509-14523
Ishiguro, Susumu; Kawabata, Atsushi; Zulbaran-Rojas, Alejandro et al. (2018) Co-treatment with a C1B5 peptide of protein kinase C? and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation. Biochem Biophys Res Commun 495:962-968
He, Chenchen; Duan, Shaofeng; Dong, Liang et al. (2017) Characterization of a novel p110?-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. Prostate 77:1187-1198
White, Peter T; Subramanian, Chitra; Zhu, Qing et al. (2016) Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion. Surgery 159:142-51
Ohta, Naomi; Ishiguro, Susumu; Kawabata, Atsushi et al. (2015) Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes. PLoS One 10:e0123756
Li, Benyi; Thrasher, James Brantley; Terranova, Paul (2015) Glycogen synthase kinase-3: a potential preventive target for prostate cancer management. Urol Oncol 33:456-63
Ishiguro, Susumu; Yoshimura, Kiyoshi; Tsunedomi, Ryouichi et al. (2015) Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Biol Ther 16:307-16
Standard, Joseph; Jiang, Yu; Yu, Miao et al. (2014) Reduced signaling of PI3K-Akt and RAS-MAPK pathways is the key target for weight-loss-induced cancer prevention by dietary calorie restriction and/or physical activity. J Nutr Biochem 25:1317-23
Peterson, Kenneth R; Costa, Flávia C; Fedosyuk, Halyna et al. (2014) A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. PLoS One 9:e107006
Kong, Bo; Huang, Jiansheng; Zhu, Yan et al. (2014) Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol 306:G893-902

Showing the most recent 10 out of 240 publications